Molecular mechanism of the acquisition of new-quinolone resistance in mycobacterium leprae and M. Tuberculosis and rapid differentiation methods for resistant bacilli

3Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Drugs included in new-quinolone are used for the treatment of leprosy with single lesion. These drugs are also known to be effective drugs for the treatment of multi-drug resistant M. tuberculosis. Recent emergence of new-quinolone resistant M. leprae and M. tuberculosis enforced the urgent elucidation of the mode of emergence of new-quinolone resistant strains. In this review, new-quinolone drugs, their mode of action and mechanism of acquisition of resistance by M. leprae and M. tuberculosis were explained. And rapid differentiation methods for resistant bacilli were also introduced.

Cite

CITATION STYLE

APA

Kim, H., Suzuki, H., Matsuoka, M., Matsuba, T., Yokoyama, K., Nakajima, C., & Suzuki, Y. (2011). Molecular mechanism of the acquisition of new-quinolone resistance in mycobacterium leprae and M. Tuberculosis and rapid differentiation methods for resistant bacilli. Japanese Journal of Leprosy, 80(1), 17–27. https://doi.org/10.5025/hansen.80.17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free